<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://jac.oxfordjournals.org/content/45/4/417.full">
<meta name="wpd_url" content="http://jac.oxfordjournals.org/content/45/4/417.full">
<meta name="wpd_date" content="2013-04-23T16:39Z">
<script async="" src="cb=gapi.loaded_0"></script>
      
      <title>NNRTIs—a new class of drugs for HIV </title>
      <meta name="googlebot" content="NOODP">
      <meta name="HW.ad-path" content="/cgi/content/full/45/4/417">
      <meta content="/jac/45/4/417.atom" name="HW.identifier">
      <meta name="DC.Format" content="text/html">
      <meta name="DC.Language" content="en">
      <meta content="NNRTIs—a new class of drugs for HIV" name="DC.Title">
      <meta content="10.1093/jac/45.4.417" name="DC.Identifier">
      <meta content="2000-04-01" name="DC.Date">
      <meta content="Oxford University Press" name="DC.Publisher">
      <meta content="Susan M. Drake" name="DC.Contributor">
      <meta content="Journal of Antimicrobial Chemotherapy" name="citation_journal_title">
      <meta content="J. Antimicrob. Chemother." name="citation_journal_abbrev">
      <meta content="0305-7453" name="citation_issn">
      <meta content="1460-2091" name="citation_issn">
      <meta name="citation_author" content="Susan M. Drake">
      <meta content="NNRTIs—a new class of drugs for HIV" name="citation_title">
      <meta content="04/01/2000" name="citation_date">
      <meta content="45" name="citation_volume">
      <meta content="4" name="citation_issue">
      <meta content="417" name="citation_firstpage">
      <meta content="420" name="citation_lastpage">
      <meta content="45/4/417" name="citation_id">
      <meta content="jac;45/4/417" name="citation_mjid">
      <meta content="10.1093/jac/45.4.417" name="citation_doi">
      <meta content="http://jac.oxfordjournals.org/content/45/4/417.full" name="citation_fulltext_html_url">
      <meta content="http://jac.oxfordjournals.org/content/45/4/417.full.pdf" name="citation_pdf_url">
      <meta content="http://jac.oxfordjournals.org/content/45/4/417" name="citation_public_url">
      <meta content="10747817" name="citation_pmid">
      <meta name="citation_section" content="Leading Article">
      <meta name="robots" content="noarchive,nofollow">
      <meta name="googlebot" content="noarchive">
      <link href="http://jac.oxfordjournals.org/content/45/suppl_2/25.short" rel="prev">
      <link href="http://jac.oxfordjournals.org/content/45/4/421.short" rel="next">
      
      
      
      
      
      
      
      
      <script type="text/javascript" id="session-d85170666e1">var callbackToken='462CE8643326B08';</script><script type="text/javascript" id="session-d85170666e3">

                      var subCode='oupjournal_sub';
                    </script><script type="text/javascript" src="jquery-min.js"></script><script type="text/javascript" src="hw-shared.js"></script><script type="text/javascript" src="hw-publisher-site.js"></script><script type="text/javascript" src="local-js-vars.js"></script><script type="text/javascript" src="hw-content.js"></script><script type="text/javascript" src="AccessCheckLib.js"></script><script type="text/javascript" src="executeAccessCheck.js"></script><script type="text/javascript" src="jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="jquery.easing-1.3.pack.js"></script><script type="text/javascript" src="jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="content.jquery.addVariantLink.js"></script><script type="text/javascript" src="hw-col-expand.js"></script><script type="text/javascript" src="hw-publisher-article-dynamic-elements.js"></script><script type="text/javascript" src="hw-mathjax.js"></script><script type="text/x-mathjax-config;executed=true">

          MathJax.Hub.Config({
              tex2jax: {
                inlineMath: [["$","$"],["\\(","\\)"]],
                processClass: "tex2jax_process|mathjax"
              }
            });
       </script><script type="text/javascript" src="MathJax.js"></script>
      
      
      
      
      <script type="text/javascript" src="main.js"></script>
      <script type="text/javascript" src="oup_ad_size.js"></script><script src="common"></script><script src="policy"></script><script src="custom-script.js"></script><script src="oxford-www"></script>
<link rel="stylesheet" type="text/css" href="417.css" media="all">
</head>
<body class="general_page journal jac tex2jax_ignore"><div id="dic_bubble" class="selection_bubble fontSize13 noSelect" style="z-index: 9999; border: 1px solid rgb(74, 174, 222);"></div><div><div id="cookiepolicy_div"><a id="cookiepolicy_link" href="#cookiepolicy_data"></a><div id="cookiepolicy_parent" style="display: none;"><div id="cookiepolicy_data"></div></div></div></div><div style="display: none;" id="MathJax_Message"></div>
      <div class="hw-gen-page pagetype-content hw-pub-id-article" id="pageid-content" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle">
         <noscript>

            <p>We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of
               cookies. You can change your cookie settings at any time. <a href="http://global.oup.com/cookiepolicy/">Find out more</a></p>
         </noscript>
         
         
         <p class="hide">
            <a href="#content">Skip Navigation</a>
            
         </p>
         
         
         <div id="secondary_nav">
            <strong id="page_logo" title="Oxford Journals"><a href="http://www.oxfordjournals.org/"><span>Oxford Journals</span></a></strong>
            
            <ul>
               <li id="nav_contact_us" title="Contact Us"><a href="http://www.oxfordjournals.org/contact_us.html"><span>Contact Us</span></a></li>
               <li id="nav_my_basket" title="My Basket"><a href="https://secure.oxfordjournals.org/basket.html"><span>My Basket</span></a></li>
               <li id="nav_my_account" title="My Account"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http://www.oxfordjournals.org/service/Register"><span>My 
                        
                        Account</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="header">
            
            <h1 id="page_title" title="Journal of Antimicrobial Chemotherapy"><a href="http://jac.oxfordjournals.org/"><span>

                     Journal of Antimicrobial Chemotherapy
                     </span></a></h1>
            
         </div>
         
         
         <div id="primary_nav">
            
            <ul>
               <li id="nav_about_this_journal" title="About This Journal">
                  <a href="http://www.oxfordjournals.org/jac/about.html">
                     
                     <span>About This Journal</span>
                     </a>
                  
               </li>
               <li id="nav_contact_this_journal" title="Contact This Journal"><a href="http://jac.oxfordjournals.org/cgi/feedback/"><span>Contact This Journal</span></a></li>
               <li id="nav_subscriptions" title="Subscriptions">
                  <a href="http://www.oxfordjournals.org/jac/access_purchase/buy_online.html">
                     
                     <span>Subscriptions</span>
                     </a>
                  
               </li>
               <li id="nav_current_issue" title="Current"><a href="http://jac.oxfordjournals.org/content/current"><span>View Current Issue (Volume 68 Issue 6 June 2013)</span></a></li>
               <li id="nav_archive" title="Archive"><a href="http://jac.oxfordjournals.org/content/by/year"><span>Archive</span></a></li>
               <li id="nav_search" title="Search"><a href="http://jac.oxfordjournals.org/search"><span>Search</span></a></li>
            </ul>
            
         </div>
         
         
         <div id="user_nav">
            
            <div class="header-ac-elements">
               
               <div id="authstring">
                  
                  <ul>
                     <li class="subscr-ref">Institution:  University of the Western Cape</li>
                     <li class="no-left-border">
                        <a href="http://jac.oxfordjournals.org/login?uri=http%3A%2F%2Fjac.oxfordjournals.org%2Fcontent%2F45%2F4%2F417.full">

                           Sign In as Personal Subscriber
                           </a>
                        
                     </li>
                  </ul>           
                  
               </div>   
               
            </div>
            
         </div>
         
         
         <ul id="site-breadcrumbs">
            <li class="first"><a href="http://services.oxfordjournals.org/cgi/tslogin?url=http%3A%2F%2Fwww.oxfordjournals.org">Oxford Journals</a></li>
            <li><span class="breadcrumb_subjects"><a href="http://www.oxfordjournals.org/subject/medicine/" class="breadcrumb_subject">Medicine</a> <span class="ampersand"></span> </span></li>
            <li><a href="http://jac.oxfordjournals.org/">Journal of Antimicrobial Chemotherapy</a></li>
            <li><a href="http://jac.oxfordjournals.org/content/45/4.toc">
                  <span xmlns="" class="volume-value">Volume 45<span class="vol-issue-comma">,</span></span>
                  <span xmlns="" class="issue-value"> Issue 4</span></a></li>
            <li>Pp. <span class="slug-pages">

                  417-420.
                  </span></li>
         </ul>
         
         
         
         
         <div id="oas_top" class="ad_hidden">
            <iframe id="id_advertframe_top" src="417_1.html" class="resize_ad usmonndchupfwwcnugwg" frameborder="0" height="0" scrolling="no" width="0"></iframe>
            
         </div>
         
         
         <a name="content"></a>
         
         
         <div id="h20_page"></div>
         
         <div class="10.1093jac45.4.41710.1093jac45.4.417" style="height: 6206px;" id="content-block"><div class="option-box-docked" style="display: block; left: 985.5px;" id="content-option-box" title="Expand this column"><ul><li id="content-toggle"><a href="#"><span class="descr">Expand</span><span>+</span></a></li></ul></div><div id="print-slug" class="print-only"><span class="jnl-title">Journal of Antimicrobial Chemotherapy</span><span class="jnl-url">jac.oxfordjournals.org</span><div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="Journal of Antimicrobial Chemotherapy" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">J. Antimicrob. Chemother.</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">

                                    (2000) 
                                    </span>
                                 
                                 <span class="slug-vol">

                                    45
                                    </span><span class="slug-issue">

                                    (4):
                                    </span><span class="slug-pages">

                                    417-420.
                                    </span>
                                 <span class="slug-doi-wrapper">

                                    
                                    doi:
                                    
                                    <span title="10.1093/jac/45.4.417" class="slug-doi">10.1093/jac/45.4.417</span>
                                    </span>
                                 </cite>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div></div>
            <div class="article fulltext-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">NNRTIs—a new class of drugs for HIV</h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="last" id="contrib-1"><span class="name"><a class="name-search" href="http://jac.oxfordjournals.org/search?author1=Susan+M.+Drake&amp;sortspec=date&amp;submit=Submit">Susan M. Drake</a></span><a id="xref-fn-1-1" class="xref-fn" href="#fn-1">*</a></li>
                  </ol><p class="affiliation-list-reveal"><a href="#" class="view-more">+</a> Author Affiliations</p>
                  <ol class="affiliation-list hideaffil">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>Department of Sexual Medicine, Heartlands Hospital, Birmingham B9 5SS, UK</address>
                     </li>
                  </ol>
                  <ul class="history-list"></ul>
               </div>
               <p id="p-1">The non-nucleoside reverse transcriptase inhibitors (NNRTIs), nevirapine and efavirenz, are now licensed for the treatment
                  of human immunodeficiency virus (HIV) infections. A third compound, delavirdine, is licensed in the USA and available in Europe
                  on expanded access programmes. The place of NNRTIs in HIV therapy is determined by their pharmacology, their potency and their
                  acceptability to patients.
               </p>
               <div class="section" id="sec-1">
                  <div class="section-nav">
                     <div class="nav-placeholder">&nbsp;</div><a href="#sec-2" title="The physician's perspective" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>The pharmacologist's perspective</h2>
                  
                  <p id="p-2">The NNRTIs are a disparate group of compounds that act by blocking HIV-1 reverse transcriptase by direct binding. They require
                     neither intracellular phosphorylation nor significantly affect other enzyme systems. As the three drugs differ structurally
                     they have different pharmacokinetic properties. Both efavirenz and nevirapine have long half-lives, such that efavirenz is
                     given once daily and nevirapine twice daily (once daily for the first 2 weeks). Delavirdine requires a three times daily dosing
                     regimen. All are well absorbed after administration without food restrictions, and efavirenz and nevirapine in particular
                     have mean trough plasma concentrations well in excess of the IC<sub>90</sub> of wild-type virus strains. Given the importance of maintaining viral suppression this gives a degree of ‘forgiveness' if
                     a dose is taken late. However, if therapy in combination with short-acting compounds is stopped abruptly, effectively, monotherapy
                     may result, with the potential for development of resistant strains of virus.
                  </p>
                  
                  <p id="p-3">Ideally, antiretroviral drugs should achieve inhibitory levels in other body compartments (e.g. the central nervous system
                     and genital tract). Fortunately nevirapine and efavirenz have both been shown to penetrate CSF, with minimum concentrations
                     above at least the IC<sub>50</sub> of wild-type virus.<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1"><sup>1</sup></a><sup>–</sup><a id="xref-ref-3-1" class="xref-bibr" href="#ref-3"><sup>3</sup></a> Nevirapine is also known to penetrate into semen.<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4"><sup>4</sup></a> There are few data on the penetration of delavirdine into CSF.<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5"><sup>5</sup></a> Nevirapine crosses the placenta and is present in breast milk.<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6"><sup>6</sup></a><sup>–</sup><a id="xref-ref-7-1" class="xref-bibr" href="#ref-7"><sup>7</sup></a> Initial reports suggest a role for single-dose nevirapine in the prevention of vertical transmission in breast-feeding women
                     in less developed countries.<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8"><sup>8</sup></a> There are no published data on penetration of delavirdine into human breast milk and efavirenz has shown marked teratogenic
                     effects in cynomolgus monkeys and should not be used during pregnancy or lactation.
                  </p>
                  
               </div>
               <div class="section" id="sec-2">
                  <div class="section-nav"><a href="#sec-1" title="The pharmacologist's perspective" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-3" title="The patient's perspective" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>The physician's perspective</h2>
                  
                  <p id="p-4">The initial combination of drugs for a treatment-naïve patient must be potent enough to reduce viral load to undetectable
                     levels and increase CD4 cell counts. Evidence of a reduction in clinical progression is also desirable but, in practice, the
                     low number of events in patients under treatment makes obtaining these data largely impractical. Other important considerations
                     when choosing a regimen will be side-effects, simplicity of dosage, the ease with which drug resistance develops and potential
                     interactions with other compounds used by the patient. Until recently, a combination of two nucleoside reverse transcriptase
                     inhibitors (NRTIs) with a protease inhibitor (PI) was the accepted first-line treatment for HIV infection. Evidence is now
                     accumulating that antiviral regimens containing an NNRTI and two NRTIs can also produce a sustained reduction in viral load
                     and increased CD4 cell counts in a high proportion of patients. The DMP 266-006 trial compared zidovudine and lamivudine,
                     in combination with either efavirenz or indinavir, in a cohort of 1266 asymptomatic or mildly symptomatic patients. At 48
                     weeks the efavirenz arm gave significantly better results than the indinavir-containing arm. First analysis to 72 weeks of
                     the full cohort demonstrates statistically significant superiority for the NNRTI arm when analysed for time to treatment failure
                     and durability of response.<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9"><sup>9</sup></a> Importantly this treatment regimen retained its potency in patients with pre-treatment viral loads of over 100 000 RNA copies/mL.
                     This was, however, an open-label study and the superiority of the efavirenzcontaining arm may, in part, be due to better adherence
                     to the simpler regimen. Other studies are in progress with efavirenz in combination with NRTIs and the initial data look encouraging.
                  </p>
                  
                  <p id="p-5">The INCAS study<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10"><sup>10</sup></a> was the first to suggest that nevirapine, zidovudine and didanosine was a potent combination and long term follow-up (over
                     3 years) has demonstrated continued viral suppression.<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11"><sup>11</sup></a> Early data from the Atlantic study, which has three arms, (two NRTIs and nevirapine, three NRTIs, and two NRTIs plus a PI),
                     have been presented.<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12"><sup>12</sup></a> Patients were all HIV-treatment naïve with a high median baseline CD4 cell count. There were no significant differences between
                     the arms at 48 weeks although the triple NRTI arm patients with high viral loads at entry were less likely to attain suppression
                     to &lt;50 RNA copies/mL.
                  </p>
                  
                  <p id="p-6">Delavirdine has been studied in combination with zidovudine and lamivudine in treatment-naïve patients and was superior to
                     the control arms of dual therapy, although this is clearly not the standard of care at present.<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13"><sup>13</sup></a><sup>,</sup><a id="xref-ref-14-1" class="xref-bibr" href="#ref-14"><sup>14</sup></a> Unlike efavirenz and nevirapine, delavirdine is a P-450 inhibitor and, thus, it improves the pharmacokinetics of indinavir.
                     Studies of delavirdine and indinavir in various combinations are still under way and, although preliminary results look promising,
                     more data are awaited.<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15"><sup>15</sup></a></p>
                  
                  <p id="p-7">Drug interactions are a major consideration in the treatment of HIV infection. Individual drugs may alter the pharmacokinetics
                     of the other components of the regimen or interact with prescribed, over-the-counter, or recreational drugs consumed by the
                     patient. This may result in subtherapeutic concentrations of antivirals and the potential for resistance development, or a
                     reduced efficacy of concomitant drugs. Alternatively, enhanced drug-related toxicities may occur. Nevirapine is an inducer
                     of hepatic cytochrome P-450 whereas delavirdine is an inhibitor of the system. Efavirenz seems to both induce and inhibit.
                     There is, therefore, the potential for interaction with any drug (including PIs, oral contraceptives, cisapride and terfenidine)
                     metabolized by this route. Detailed information on drug interactions involving antiretrovirals can be found at the Liverpool
                     University Department of Pharmacology website<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16"><sup>16</sup></a> and should be consulted before prescribing.
                  </p>
                  
                  <p id="p-8">The commonest side-effect of NNRTIs is rash, which occurs in the first few weeks and usually resolves. Normally, treatment
                     can be continued with the use of antihistamines, and possibly steroids. The incidence of rash with nevirapine and delavirdine
                     is nearly 20% but is lower with efavirenz. The major side-effects reported with efavirenz are neuropsychiatric; 52% of patients
                     report insomnia, vivid dreams and, rarely, hallucinations and ‘psychosis-like’ reactions. These symptoms occur during the
                     first days of therapy, shortly after dosing, and last a few hours only. They usually resolve within 2 to 4 weeks. Most patients
                     tolerate them if given sufficient information and support. Splitting, escalation or reduction of doses has no effect on CNS
                     side-effects. Abnormal liver-function tests have also been reported for these drugs, particularly with nevirapine. Early clinical
                     experience suggests that a patient experiencing side-effects with either efavirenz or nevirapine can sometimes be switched
                     to the other drug without recurrence of the same problem. To date no long-term or unexpected side-effects have arisen from
                     these drugs although further follow-up is required, particularly with regard to lipodystrophy.
                  </p>
                  
                  <p id="p-9">Regarding NNRTIs, the area of greatest concern for physicians is the low genetic barrier to drug resistance. The acquisition
                     of only a single mutation, leading to the K103N substitution in reverse transcriptase, appears to confer cross-class resistance
                     to all three available agents. As this mutation emerges quickly with inadequate viral suppression, use of these drugs as part
                     of a potent regimen is essential. As indicated above, this may be relevant when stopping therapy and if suboptimal penetration
                     into ‘sanctuary sites’ occurs.
                  </p>
                  
                  <p id="p-10">How then can physicians use NNRTIs to their best advantage? Clearly there is a role for the use of dual NRTIs with either
                     efavirenz, nevirapine or, possibly, delavirdine (although better data are required) in the initial therapy for naïve or minimally
                     nucleoside-exposed patients. This option has become particularly attractive as a PI-sparing regimen. The desire to avoid the
                     use of PIs, especially in early disease, has been driven by the emergence of the lipodystrophy and metabolic disturbances
                     which seem to be associated (although not exclusively) with PI-containing regimens. For patients with established lipodystrophy,
                     replacing a PI with an NNRTI sometimes results in improvements in metabolic abnormalities and body habitus without loss of
                     viral control.<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17"><sup>17</sup></a><sup>–</sup><a id="xref-ref-19-1" class="xref-bibr" href="#ref-19"><sup>19</sup></a> The place of NNRTIs in second-line and salvage therapy is being extensively investigated. Clinical experience suggests that
                     once one NNRTI has failed, success is unlikely with another of the presently available compounds, this is supported by the
                     common finding of the K103N substitution in the HIV of failing patients.<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20"><sup>20</sup></a></p>
                  
               </div>
               <div class="section" id="sec-3">
                  <div class="section-nav"><a href="#sec-2" title="The physician's perspective" class="prev-section-link"><span>Previous Section</span></a><a href="#sec-4" title="The future" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>The patient's perspective</h2>
                  
                  <p id="p-11">The ideal treatment regimen from the patient's point of view is simple and effective, with no food restrictions and easily
                     incorporated into their daily routine. In addition, side-effects and interactions with recreational substances such as alcohol
                     should be minimal. Most importantly, treatment should not produce characteristic changes in appearance that clearly identify
                     the patient as HIV-positive. The facial and limb fat wasting with central adiposity associated with PIs has severely affected
                     the social functioning and self-confidence of many patients who are otherwise well in spite of advanced disease. Patients
                     report that adherence, which is so important for good virological control,<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21"><sup>21</sup></a> is easy with NNRTIs. The simplest licensed regimen (zidovudine, lamivudine and nevirapine) requires only two pills twice
                     daily and the combination of efavirenz, zidovudine and lamivudine one pill in the morning and four pills at night with no
                     food restrictions. In contrast PI-containing combinations are much more complex. Some interactions with recreational drugs
                     do occur, e.g. nevirapine increases methadone requirements,<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22"><sup>22</sup></a> and many more data are required.
                  </p>
                  
               </div>
               <div class="section" id="sec-4">
                  <div class="section-nav"><a href="#sec-3" title="The patient's perspective" class="prev-section-link"><span>Previous Section</span></a><a href="#fn-group-1" title="Footnotes" class="next-section-link"><span>Next Section</span></a></div>
                  
                  <h2>The future</h2>
                  
                  <p id="p-12">Nevirapine and efavirenz have quickly found a place in the management of HIV infections. Doctors find them easy to prescribe
                     and patients find them easy to take. National guidelines are being changed to include their use. One possible concern is the
                     overlapping side-effect profile (rash) with other new HIV drugs. This applies to amprenavir and to abacavir which has a potentially
                     serious hypersensitivity reaction, of which rash is a component. New NNRTIs are in development, which appear active against
                     K103N-containing mutants; in the meantime, the existing compounds are a welcome addition to our armamentarium.
                  </p>
                  
                  <p id="p-13">One final note of caution—HIV physicians have learned over the last 10 years that treatment strategies formulated today will
                     almost certainly have been proved incorrect by tomorrow!
                  </p>
                  
               </div>
               <div class="section fn-group" id="fn-group-1">
                  <div class="section-nav"><a href="#sec-4" title="The future" class="prev-section-link"><span>Previous Section</span></a><a href="#ref-list-1" title="References" class="next-section-link"><span>Next Section</span></a></div>
                  <h2>Footnotes</h2>
                  <ul>
                     <li class="fn" id="fn-1">
                        
                        
                        <p id="p-14"><a class="rev-xref" href="#xref-fn-1-1">↵</a><span class="fn-label">*</span> Tel: +44-121-766-6611; Fax: +44-121-766-8752; E-mail: <a href="mailto:S.M.Drake@bham.ac.uk">S.M.Drake@bham.ac.uk</a></p>
                        
                     </li>
                  </ul>
               </div>
               <ul>
                  <li class="fn" id="copyright-statement-1">© 2000 The British Society for Antimicrobial Chemotherapy</li>
               </ul>
               <div class="section ref-list" id="ref-list-1">
                  <div class="section-nav"><a href="#fn-group-1" title="Footnotes" class="prev-section-link"><span>Previous Section</span></a><div class="nav-placeholder">&nbsp;</div>
                  </div>
                  <h2>References</h2>
                  <ol class="cit-list">
                     <li><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.1">
                           <div class="cit-metadata unstructured"> Yazdanian, M. &amp; Glynn, S. L. (1998). Nevirapine has excellent blood brain barrier permeability and absorption properties
                              compared to other HIV antiretrovirals. In <em>Conference Record of the Twelfth World AIDS Conference, Geneva</em> <em>1998</em>. Abstract 60086, p. 1016.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li>
                        
                        
                        <div class="cit ref-cit ref-other no-rev-xref" id="cit-45.4.417.2">
                           <div class="cit-metadata unstructured"> Kearney, B., Price, R., Sheiner, L., Bellibas, E., Staprans, S., Thevanayagam, L. <em>et al</em>. (1999). Estimation of nevirapine exposure within the cerebrospinal fluid using CSF: plasma area under the curve ratios.
                              In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL,</em> <em>1999</em>. Abstract 406, p. 144.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text" id="ref-3">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.3">
                           <div class="cit-metadata"><cite> Tashima, K., Caliendo, A., Ahmad, M., Gormley, J., Fiske, W. D., Brennan, J. <em>et al</em>. (<span class="cit-pub-date">1999</span>). Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected
                                 patients receiving combination therapy. <span class="cit-source"><em>Journal of Infectious Diseases</em></span> <span class="cit-vol">180</span>, <span class="cit-fpage">862</span>–4.</cite></div>
                           <div class="cit-extra"><a href="http://jac.oxfordjournals.org/cgi/ijlink?linkType=ABST&amp;journalCode=jinfdis&amp;resid=180/3/862" class="cit-ref-sprinkles cit-ref-sprinkles-ijlinks"><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text" id="ref-4">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.4">
                           <div class="cit-metadata unstructured"> Taylor, S., Van Heeswijk, R., Hoetelmans, R., Workman, J., Drake, S. &amp; Pillay, D. (1999). Penetration of nevirapine and nucleoside
                              analogues into semen of HIV-1-infected men. In <em>Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco,
                                 CA, USA, 1999</em>. Abstract 0335, p. 19. American Society for Microbiology, Washington, DC.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text" id="ref-5">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.5">
                           <div class="cit-metadata unstructured"><em>Rescriptor, Prescribing information, USA</em>.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text" id="ref-6">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.6">
                           <div class="cit-metadata unstructured"> Silverstein, H., Riska, P., Johnstone, J. N., Richter, I., Norris, S. Hattox, S. <em>et al</em>. (1996). Nevirapine, a non-nucleoside reverse transcriptase inhibitor, freely enters the brain and crosses the placental
                              barrier. In <em>Program and Abstracts of the Eleventh International Conference on AIDS, Vancouver,</em> <em>1996</em>. Abstract B.2325, p. 321.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.7">
                           <div class="cit-metadata"><cite> Musoke, P., Guay, L., Bagenda, D., Mirochnick, M., Nakabiito, C., Fleming, R. <em>et al</em>. (<span class="cit-pub-date">1999</span>). A phase I/II study of the pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates. (HIVNET
                                 006). <span class="cit-source"><em>AIDS</em></span> <span class="cit-vol">13</span>, <span class="cit-fpage">479</span>–86.</cite></div>
                           <div class="cit-extra"><a href="http://jac.oxfordjournals.org/external-ref?access_num=10.1097/00002030-199903110-00006&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jac.oxfordjournals.org/external-ref?access_num=10197376&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="http://jac.oxfordjournals.org/external-ref?access_num=000079196100006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.8">
                           <div class="cit-metadata"><cite> Guay, L., Musoke, P., Fleming, T., Bagenda, D., Allen, M., Nakabiito, C. <em>et al</em>. (<span class="cit-pub-date">1999</span>). Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission
                                 of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. <span class="cit-source"><em>Lancet.</em></span><span class="cit-vol">354</span>, <span class="cit-fpage">795</span>–802.</cite></div>
                           <div class="cit-extra"><a href="http://jac.oxfordjournals.org/external-ref?access_num=10485720&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="http://jac.oxfordjournals.org/external-ref?access_num=000082400700007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.9">
                           <div class="cit-metadata unstructured"> Staszewski, S., Morales-Ramirez, J., Godofsky, E., Stryker, R., Tashima, K., Farine, D. <em>et al</em>. (1999). Longer time-to-treatment failure and durability of response with efavirenz + ZDV+3TC: first analysis of full 1266
                              patient cohort from Study 006. In <em>Program and Abstracts of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco,
                                 CA, USA, 1999</em>. Abstract 507, p. 473. American Society for Microbiology, Washington, DC.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.10">
                           <div class="cit-metadata"><cite>Montaner, J., Reiss, P., Cooper, D., Vella, S., Harris, B., Conway, B. <em>et al</em>. (<span class="cit-pub-date">1998</span>). A randomized double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients:
                                 the INCAS trial. <span class="cit-source"><em>Journal of the American Medical Association</em></span> <span class="cit-vol">279</span>, <span class="cit-fpage">930</span>–7.</cite></div>
                           <div class="cit-extra"><a href="http://jac.oxfordjournals.org/external-ref?access_num=10.1001/jama.279.12.930&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">CrossRef</a><a href="http://jac.oxfordjournals.org/external-ref?access_num=9544767&amp;link_type=MED" class="cit-ref-sprinkles cit-ref-sprinkles-medline">Medline</a><a href="http://jac.oxfordjournals.org/external-ref?access_num=000072563600033&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-webofscience">Web of Science</a></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.11">
                           <div class="cit-metadata unstructured">Robinson, P. &amp; Montaner, J. (1998). Long-term follow-up of patients treated with nevirapine (NVP) based combination therapy
                              within the INCAS trial. In <em>Conference Record of the Twelfth World AIDS Conference, Geneva</em> <em>1998</em>. Abstract 12368, p. 87.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.12">
                           <div class="cit-metadata unstructured">Murphy, R., Katlama, C., Johnson, V., Squires, K., Horban, A., Gatell, J. <em>et al</em>. (1999). The Atlantic Study: A randomized open-label trial comparing two protease inhibitor (PI)-sparing antiretroviral strategies
                              versus a standard PI-containing regimen, 48 week data. In <em>Abstract Addendum of the Thirty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA,
                                 USA, 1999</em>. Abstract LB-22, p. 18.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.13">
                           <div class="cit-metadata unstructured">Green, S. L., Para, M. F., Daly, P. W., Freimuth, W. W., Getchel, L. D., Wathen, L. K. <em>et al</em>. (1998). Interim analysis of plasma viral burden reductions and CD4 increases in HIV-1 infected patients with Rescriptor
                              (DLV) + Retrovir (ZDV) + Epivir (3TC). In <em>Conference Record of the Twelfth World AIDS Conference, Geneva,</em> <em>1998</em>. Abstract 12219, p. 55.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.14">
                           <div class="cit-metadata unstructured">Wood, R., Hawkins, D. A., Moyle, G., De Cian, W., Ingrosso, A. &amp; Greenwald, C. (1999). Second placebo-controlled study in
                              naive individuals confirms the role of delavirdine in highly active antiretroviral, protease-sparing treatment. In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract 624, p. 185.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text" id="ref-15">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.15">
                           <div class="cit-metadata unstructured">Eron, J., Walmsley, S., Wathen, L., Paxton, L., Huang, D., Freimuth, W. <em>et al</em>. (1999). Sustained viral suppression with delavirdine and indinavir combination therapies. In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract 384, p. 140.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.16">
                           <div class="cit-metadata unstructured">Liverpool HIV Pharmacology Group website. Copyright 1999. [Online.] Published by University of Liverpool. [last accessed January
                              2000] <a href="http://www.liv.ac.uk/hivgroup">http://www.liv.ac.uk/hivgroup</a></div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.17">
                           <div class="cit-metadata unstructured">Raffi, F., Bonnet, B., Ferre, V., Leautez, S., Reliquet, V., Allavena, C. <em>et al</em>. (1999). Substitution of NNRTI for protease inhibitor in patients on combination therapy with undetectable plasma viral loads.
                              In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract 381, p. 139.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li>
                        
                        
                        <div class="cit ref-cit ref-other no-rev-xref" id="cit-45.4.417.18">
                           <div class="cit-metadata unstructured">Moyle, G., Baldwin, C., Dent, N. &amp; Gazzard, B. (1999). Management of indinavir-associated metabolic changes by substitution
                              with efavirenz in virologically controlled HIV+ persons. In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract 669, p. 193.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.19">
                           <div class="cit-metadata unstructured">Ruiz, L., Bonjoch, A., Paredes, R., Johnston, S., Arnó, A., Romeu, J. <em>et al</em>. (1999). A multi-center, randomized, open-label, comparative trial of the clinical benefit of switching the protease inhibitor
                              (PI) by nevirapine (NVP) in HAART-experienced patients suffering lipodystrophy (LD). In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract LB14, p. 207.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.20">
                           <div class="cit-metadata unstructured">Jeffrey, S., Corbett, J &amp; Bacheler, L. (1999). <em>In vitro</em> NNRTI resistance of recombinant HIV carrying mutations observed in efavirenz treatment failures. In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract 110, p. 88.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.21">
                           <div class="cit-metadata unstructured">Paterson, D., Swindells, S., Mohr, J., Brester, M., Vergis, E., Squier, C. <em>et al</em>. (1999). How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMSCaps. In
                              <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract 92, p. 84.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                     <li><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">↵</a>
                        
                        
                        <div class="cit ref-cit ref-other" id="cit-45.4.417.22">
                           <div class="cit-metadata unstructured">Altice, F. L., Cooney, E. &amp; Friendland, G. H. (1999). Nevirapine induced methadone withdrawal: implications for antiretroviral
                              treatment of opiate dependent HIV infected patients. In <em>Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, USA,</em> <em>1999</em>. Abstract 372, p. 137.
                           </div>
                           <div class="cit-extra"></div>
                        </div>
                        
                     </li>
                  </ol>
               </div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span><div xmlns="http://www.w3.org/1999/xhtml" id="cited-by"><h2>Articles citing this article</h2><ul class="cited-by-list"><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Nonnucleoside Inhibitor Binding Affects the Interactions of the Fingers Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase with DNA </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date"><span class="cit-sep cit-sep-before-article-print-date">(</span>2004<span class="cit-sep cit-sep-after-article-print-date">)</span> </span><span class="cit-vol">78</span><span class="cit-issue"><span class="cit-sep cit-sep-before-article-issue">(</span>7<span class="cit-sep cit-sep-after-article-issue">):</span> </span><span class="cit-pages"><span class="cit-first-page">3387</span><span class="cit-sep">-</span><span class="cit-last-page">3397</span> </span></cite>  </div><div class="cit-extra"><span class="accesscheck jvi;78/7/3387 abstract,full,reprint"></span> <ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/78/7/3387" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/78/7/3387" rel="full-text">Full Text (HTML)</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/78/7/3387" rel="full-text.pdf">Full Text (PDF)</a></li></ul>  </div> </li></ul></div></div>
         <div style="height: 6206px;" id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="http://jac.oxfordjournals.org/content/45/suppl_2/25.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="http://jac.oxfordjournals.org/content/45/4/421.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="http://jac.oxfordjournals.org/content/45/4.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">
                              
                              <cite>
                                 <abbr title="Journal of Antimicrobial Chemotherapy" class="slug-jnl-abbrev">
                                    <nlm:abbrev-journal-title xmlns:nlm="http://schema.highwire.org/NLM/Journal" abbrev-type="publisher">J. Antimicrob. Chemother.</nlm:abbrev-journal-title></abbr><span class="slug-pub-date" itemprop="datePublished">

                                    (2000) 
                                    </span>
                                 
                                 <span class="slug-vol">

                                    45
                                    </span><span class="slug-issue">

                                    (4):
                                    </span><span class="slug-pages">

                                    417-420.
                                    </span>
                                 <span class="slug-doi-wrapper">

                                    
                                    doi:
                                    
                                    <span title="10.1093/jac/45.4.417" class="slug-doi">10.1093/jac/45.4.417</span>
                                    </span>
                                 </cite>
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><a href="http://jac.oxfordjournals.org/content/45/4/417.extract" rel="view-extract">Extract</a><span class="viewspecificaccesscheck jac;45/4/417 abstract free">Free</span></li>
                        <li class="notice full-text-view-link"><span class="variant-indicator">» <span>Full Text (HTML)</span></span><span class="viewspecificaccesscheck jac;45/4/417 full free">Free</span></li>
                        <li class="notice full-text-pdf-view-link"><a href="http://jac.oxfordjournals.org/content/45/4/417.full.pdf+html" rel="view-full-text.pdf">Full Text (PDF)</a><span class="viewspecificaccesscheck jac;45/4/417 reprint free">Free</span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Classifications</span></a></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search" href="http://jac.oxfordjournals.org/search?tocsectionid=Leading+article&amp;sortspec=date&amp;submit=Submit">Leading Article</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Services</span></a></h4>
                     <ol>
                        <li class="alert-link icon-link"><a href="http://jac.oxfordjournals.org/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=jac;45/4/417&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jac.oxfordjournals.org/content/45/4/417.full">Alert me when cited</a></li>
                        <li class="alert-link icon-link"><a href="http://jac.oxfordjournals.org/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=45/4/417&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://jac.oxfordjournals.org/content/45/4/417.full">Alert me if corrected</a></li>
                        <li class="similar-link"><a href="http://jac.oxfordjournals.org/search?qbe=jac;45/4/417&amp;citation=Drake%2045%20%284%29:%20417&amp;submit=yes">Find similar articles</a></li>
                        <li class="similar-link"><a xmlns="http://www.w3.org/1999/xhtml" href="http://jac.oxfordjournals.org/external-ref?access_num=jac;45/4/417&amp;link_type=ISI_RELATEDRECORDS">Similar articles in Web of Science</a></li>
                        <li class="similar-link"><a href="http://jac.oxfordjournals.org/external-ref?access_num=10747817&amp;link_type=MED_NBRS" class="similar-link">Similar articles in PubMed</a></li>
                        <li class="folder-link icon-link"><a href="http://jac.oxfordjournals.org/cgi/folders?action=addtofolder&amp;wherefrom=JOURNALS&amp;wrapped_id=jac;45/4/417">Add to my archive</a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="http://jac.oxfordjournals.org/citmgr?gca=jac;45/4/417">Download citation</a></li>
                        <li><a class="request-permissions" href="https://s100.copyright.com/AppDispatchServlet?publisherName=oup&amp;publication=jac&amp;title=NNRTIs%E2%80%94a%20new%20class%20of%20drugs%20for%20HIV%3A%20&amp;publicationDate=04%2F01%2F2000&amp;author=Susan%20M.%20Drake&amp;copyright=Oxford%20University%20Press&amp;contentID=10.1093%2Fjac%2F45.4.417&amp;volumeNum=45&amp;issueNum=4&amp;startPage=417&amp;endPage=420&amp;orderBeanReset=true" target="_top">Request Permissions</a></li>
                        <li><a class="disclaimer" href="http://www.oxfordjournals.org/our_journals/jac/disclaimer.html">Disclaimer</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-cit">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Citing Articles</span></a></h4>
                     <ol style="display: none;">
                        <li class="hw-citing-link"><a href="#cited-by">View citing article information</a></li>
                        <li><a title="[opens in a new window]" target="_top" href="http://jac.oxfordjournals.org/cgi/crossref-forward-links/45/4/417" rel="external-nw" id="cb-crossref-citing-articles">Citing articles via CrossRef</a></li>
                        <li class="nodata"><div id="cb-loaded-scopus-cited-none">No Scopus citing articles</div></li>
                        <li><a xmlns="http://www.w3.org/1999/xhtml" href="http://jac.oxfordjournals.org/external-ref?access_num=jac;45/4/417&amp;link_type=ISI_CITING&amp;external_url=http%3A%2F%2Fgateway.webofknowledge.com%2Fgateway%2FGateway.cgi%3FGWVersion%3D2%26SrcApp%3DPARTNER_APP%26SrcAuth%3Dstanwire%26KeyUT%3D000086537500001%26DestLinkType%3DCitingArticles%26DestApp%3DWOS_CPL%26UsrCustomerID%3D269fc60adb004b0b719031a97aedf5e9">Citing articles via Web of Science (11)</a></li>
                        <li><a href="http://jac.oxfordjournals.org/external-ref?access_num=http://jac.oxfordjournals.org/content/45/4/417.extract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-gs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Google Scholar</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ADrake%20author%3AS.M.%22" class="cb-art-gs-auth author-link">Articles by  Drake, S. M.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="http://jac.oxfordjournals.org/external-ref?access_num=http://jac.oxfordjournals.org/content/45/4/417.extract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-pm">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>PubMed</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="http://jac.oxfordjournals.org/external-ref?access_num=10747817&amp;link_type=PUBMED" class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://jac.oxfordjournals.org/external-ref?access_num=Drake%20SM&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Drake, S. M.</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed nodata" id="cb-art-rel">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Related Content</span></a></h4>
                     <ol style="display: none;">
                        <li class="nodata"><div id="cb-loaded-related-urls-none">No related web pages</div></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-soc">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Share</span></a></h4>
                     <ol>
                        <li><a title="email this" href="http://jac.oxfordjournals.org/email?gca=jac;45/4/417&amp;current-view-path=/content/45/4/417.full"></a></li>
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a target="_BLANK" href="http://jac.oxfordjournals.org/external-ref?tag_url=http://jac.oxfordjournals.org/cgi/content/long/45/4/417&amp;title=NNRTIs%E2%80%94a%20new%20class%20of%20drugs%20for%20HIV+--+Drake%2045%20%284%29%3A%20417+--+&amp;doi=10.1093/jac/45.4.417&amp;link_type=CITEULIKE"><img src="citeulike.gif" alt="Add to CiteULike" title="CiteULike"></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a target="_BLANK" href="http://jac.oxfordjournals.org/external-ref?tag_url=http://jac.oxfordjournals.org/cgi/content/long/45/4/417&amp;title=NNRTIs%E2%80%94a%20new%20class%20of%20drugs%20for%20HIV+--+Drake%2045%20%284%29%3A%20417+--+&amp;doi=10.1093/jac/45.4.417&amp;link_type=DEL_ICIO_US"><img src="delicious.gif" alt="Add to Delicious" title="Delicious"></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a title="[opens in a new window]" target="_BLANK" href="http://jac.oxfordjournals.org/external-ref?tag_url=http://jac.oxfordjournals.org/cgi/content/short/45/4/417&amp;title=NNRTIs%E2%80%94a%20new%20class%20of%20drugs%20for%20HIV+--+Drake%2045%20%284%29%3A%20417+--+&amp;doi=10.1093/jac/45.4.417&amp;link_type=FACEBOOK" class="sb-facebook" rel="external-nw"><img src="facebook.gif" alt="Add to Facebook" title="Facebook"></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><div id="___plusone_0" style="text-indent: 0px; margin: 0px; padding: 0px; background: none repeat ; 0% transparent; border-style: none; float: none; line-height: normal; font-size: 1px; vertical-align: baseline; display: inline-block; width: 24px; height: 15px;"><iframe title="+1" data-gapiattached="true" allowtransparency="true" src="417_2.html" name="I0_1369325312688" id="I0_1369325312688" vspace="0" tabindex="0" style="position: static; top: 0px; width: 24px; margin: 0px; border-style: none; left: 0px; visibility: visible; height: 15px;" marginwidth="0" marginheight="0" hspace="0" frameborder="0" scrolling="no" width="100%"></iframe></div><a style="display: none;" target="_BLANK" href="http://jac.oxfordjournals.org/external-ref?tag_url=http://jac.oxfordjournals.org/cgi/content/long/45/4/417&amp;title=NNRTIs%E2%80%94a%20new%20class%20of%20drugs%20for%20HIV+--+Drake%2045%20%284%29%3A%20417+--+&amp;doi=10.1093/jac/45.4.417&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="googleplus.jpg" alt="Add to Google+" title="Google+"></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a target="_BLANK" href="http://jac.oxfordjournals.org/external-ref?tag_url=http://jac.oxfordjournals.org/cgi/content/long/45/4/417&amp;title=NNRTIs%E2%80%94a%20new%20class%20of%20drugs%20for%20HIV+--+Drake%2045%20%284%29%3A%20417+--+&amp;doi=10.1093/jac/45.4.417&amp;link_type=MENDELEY"><img src="mendeley.gif" alt="Add to Mendeley" title="Mendeley"></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a target="_BLANK" href="http://jac.oxfordjournals.org/external-ref?tag_url=http://jac.oxfordjournals.org/cgi/content/long/45/4/417&amp;title=NNRTIs%E2%80%94a%20new%20class%20of%20drugs%20for%20HIV+--+Drake%2045%20%284%29%3A%20417+--+&amp;doi=10.1093/jac/45.4.417&amp;link_type=TWITTER"><img src="twitter.gif" alt="Add to Twitter" title="Twitter"></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="http://jac.oxfordjournals.org/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            <div class="content-box" id="article-dyn-nav">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>Navigate This Article</span></h3>
                  <div class="cb-section" id="cb-art-nav">
                     <ol>
                        <li><a href="#content-block">Top</a></li>
                        <li><a href="#sec-1">The pharmacologist's perspective</a></li>
                        <li><a href="#sec-2">The physician's perspective</a></li>
                        <li><a href="#sec-3">The patient's perspective</a></li>
                        <li><a href="#sec-4">The future</a></li>
                        <li><a href="#fn-group-1">Footnotes</a></li>
                        <li><a href="#ref-list-1">References</a></li>
                     </ol>
                  </div>
               </div>
            </div>
            
            <div class="content-box" id="article-cb-main">
               
               <div class="cb-contents">
                  
                  <div class="cb-section collapsible default-open" id="cb-art-bn">
                     
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> 
                        <span>People also read [Beta]</span>
                        
                     </a></h4>
                     
                     <ul>
                        <li>
                           
                           <div id="bnArticleRecs"><h4 class="cb-contents-header">
<span style="margin-top: 10px;"></span>
</h4><ol style="padding-right: 5px;">
<li>
<div id="bn_g_resultbnArticleRecs_1" class="bn_g_result bn_g_result" style="margin: 0px auto; padding: 0px;">
<div class="bn_g_result_title" style="margin: 0px auto; padding: 0px 5px 4px 0px;">
<a class="bn_g_result_link" baynote_req="ArticlePage" baynote_guide="RecentPopular" baynote_bnrank="1" href="http://cid.oxfordjournals.org/cgi/doi/10.1086/508667">The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America<div class="bn_mouseoverdiv">
<span class="bn_journaltitle"><b>Clinical Infectious Diseases</b> - 2006</span>
<br>
<span class="bn_authorslist">Wormser, Gary P.; Dattwyler, Raymond J.; Shapiro, Eugene D.; Halperin, John J.; Steere, Allen C.; Klempner, Mark S.; Krause, Peter J.; Bakken, Johan S.; Strle, Franc; Stanek, Gerold; Bockenstedt, Linda; Fish, Durland; Dumler, J. Stephen; Nadelman, Ro</span>
<br>
<span class="bn_viewCount">1614 readers also viewed this
                     </span>
</div>
</a>
</div>
</div>
<div id="bn_g_resultbnArticleRecs_2" class="bn_g_result bn_g_result" style="margin: 0px auto; padding: 0px;">
<div class="bn_g_result_title" style="margin: 0px auto; padding: 0px 5px 4px 0px;">
<a class="bn_g_result_link" baynote_req="ArticlePage" baynote_guide="RecentPopular" baynote_bnrank="2" href="http://cid.oxfordjournals.org/cgi/doi/10.1093/cid/ciq146">Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children<div class="bn_mouseoverdiv">
<span class="bn_journaltitle"><b>Clinical Infectious Diseases</b> - 2011</span>
<br>
<span class="bn_authorslist">Liu, Catherine; Bayer, Arnold; Cosgrove, Sara E.; Daum, Robert S.; Fridkin, Scott K.; Gorwitz, Rachel J.; Kaplan, Sheldon L.; Karchmer, Adolf W.; Levine, Donald P.; Murray, Barbara E.; J. Rybak, Michael; Talan, David A.; Chambers, Henry F.</span>
<br>
<span class="bn_viewCount">1253 readers also viewed this
                     </span>
</div>
</a>
</div>
</div>
<div id="bn_g_resultbnArticleRecs_3" class="bn_g_result bn_g_result" style="margin: 0px auto; padding: 0px;">
<div class="bn_g_result_title" style="margin: 0px auto; padding: 0px 5px 4px 0px;">
<a class="bn_g_result_link" baynote_req="ArticlePage" baynote_guide="RecentPopular" baynote_bnrank="3" href="http://brain.oxfordjournals.org/cgi/doi/10.1093/brain/awl234">The power of music<div class="bn_mouseoverdiv">
<span class="bn_journaltitle"><b>Brain</b> - 2006</span>
<br>
<span class="bn_authorslist">Sacks, Oliver</span>
<br>
<span class="bn_viewCount">1249 readers also viewed this
                     </span>
</div>
</a>
</div>
</div>
</li>
</ol>
</div>
                           
                        </li>
                        <li>
                           
                           <p id="bnHelp">
                              <a href="http://www.oxfordjournals.org/our_journals/help.html">What's this?</a>
                              
                           </p>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               
            </div>
            
            
         </div>
         <div style="height: 6206px;" id="col-3">
            
            <div id="col-3-qs" class="sidebar-qs">
               
               
               <form class="searchbox" action="http://jac.oxfordjournals.org/search" method="get">
                  <p>Search this journal:</p>
                  <div>
                     	
                     	
                     	<input value="" name="fulltext" id="header-qs-input" type="text">
                     <input name="submit" value="yes" type="hidden">
                     <input class="inline_button" alt="Go" src="go.gif" type="image">
                     
                     <div class="adv-search-link"><a href="http://jac.oxfordjournals.org/search">Advanced »</a></div>
                     
                     
                  </div>
               </form>
               
            </div>
            <div class="cb-contents">
               
               <div id="sidebar-current-issue" class="content-box">
                  	
                  <h3 class="cb-contents-header">Current Issue</h3>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           	      <a href="http://jac.oxfordjournals.org/content/current"><span>
                                 		  <span class="current-issue-date">

                                    June 2013
                                    </span><span class="toc-citation-volume">

                                    
                                    68
                                    </span><span class="toc-citation-issue">(6)</span>
                                 		  
                                 		</span></a>
                           	    
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section">
                     	  
                     <ol>
                        <li>
                           <a href="http://jac.oxfordjournals.org/content/current"><img src="6.cover.gif" alt="Journal of Antimicrobial Chemotherapy" id="cover"></a>
                           
                        </li>
                     </ol>
                     	
                  </div>
                  	
                  <div class="cb-section sidebar-etoc-link">
                     	  
                     <ol>
                        <li><a href="http://jac.oxfordjournals.org/cgi/alerts/etoc">Alert me to new issues</a></li>
                     </ol>
                     	
                  </div>
                  
               </div>
               
            </div>
            
            <div id="second">
               
               <div class="features">
                  
                  <div class="feature separator_after first">
                     
                     <h2 id="the_journal" title="The Journal"><span>The Journal</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/jac/about.html" title="About this journal">About this journal</a>
                           
                        </li>
                        <li>
                           <a href="http://jac.oxfordjournals.org/content/by/section/Leading%20article" title="Free leading articles">Free leading articles</a>
                           
                        </li>
                        <li>
                           <a href="http://jac.oxfordjournals.org/content/by/section/Editorials" title="Free Editorials">Free Editorials</a>
                           
                        </li>
                        <li>
                           <a href="http://jac.oxfordjournals.org/supplements.dtl" title="JAC Supplements">JAC Supplements</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/rights_permissions.html" title="Rights &amp; Permissions">Rights &amp; Permissions</a>
                           
                        </li>
                        <li>
                           <a href="http://www.publicationethics.org/" title="This journal is a member of the Committee on Publication Ethics">This journal is a member of the Committee on Publication Ethics</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/mobile_faqs.html" title="We are mobile – find out more">We are mobile – find out more</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Published on behalf of</h3>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.bsac.org.uk/" title="The British Society for Antimicrobial Chemotherapy">The British Society for Antimicrobial Chemotherapy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature separator_after">
                     
                     <h3>Impact factor:  5.068</h3>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h3>Editor-in-Chief</h3>
                     
                     <div class="contact">
                        
                        <div class="name">Prof Alan P. Johnson</div>
                        
                        <div class="clear"></div>
                        
                     </div>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/jac/editorial_board.html" title="View full editorial board">View full editorial board</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="for_authors" title="For Authors"><span>For Authors</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/jac/for_authors/" title="Instructions to authors">Instructions to authors</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/jac/for_authors/online_submission.html" title="Online submission instructions">Online submission instructions</a>
                           
                        </li>
                        <li>
                           <a href="http://mc.manuscriptcentral.com/oup/jac" title="Submit Now!">Submit Now!</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html" title="Self-archiving policy">Self-archiving policy</a>
                           
                        </li>
                     </ul>
                     <a href="http://www.oxfordjournals.org/oxfordopen/">
                        <img alt="Open access options for authors – visit Oxford Open" src="oxford_open_small.gif">
                        </a>
                     
                     <p>Open access options for authors - visit <a href="http://www.oxfordjournals.org/oxfordopen/">Oxford Open</a>
                        
                     </p>
                     <a href="http://publicaccess.nih.gov/submit_process_journals.htm">
                        <img alt="PMC Logo" src="pmc-logo.gif">
                        </a>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://publicaccess.nih.gov/submit_process_journals.htm" title="This journal enables compliance with the NIH Public Access Policy">This journal enables compliance with the NIH Public Access Policy</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="alerting_services" title="Alerting Services"><span>Alerting Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://jac.oxfordjournals.org/cgi/alerts/etoc" title="Email table of contents">Email table of contents</a>
                           
                        </li>
                        <li>
                           <a href="http://jac.oxfordjournals.org/cgi/alerts/etoc" title="Email Advance Access">Email Advance Access</a>
                           
                        </li>
                        <li>
                           <a href="http://jac.oxfordjournals.org/help/citetrack" title="CiteTrack">CiteTrack</a>
                           
                        </li>
                        <li>
                           <a href="http://jac.oxfordjournals.org/rss" title="XML RSS feed">XML RSS feed</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
                  <div class="feature">
                     
                     <h2 id="corporate_services" title="Corporate Services"><span>Corporate Services</span></h2>
                     
                     <ul class="emphasised">
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/advertising.html" title="Advertising sales">Advertising sales</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/reprints.html" title="Reprints">Reprints</a>
                           
                        </li>
                        <li>
                           <a href="http://www.oxfordjournals.org/corporate_services/supplements.html" title="Supplements">Supplements</a>
                           
                        </li>
                     </ul>
                     
                  </div>
                  
               </div>
               
               <div class="ad_hidden" id="oas_right1">
                  <iframe id="id_advertframe_right1" src="417_3.html" class="resize_ad usmonndchupfwwcnugwg" frameborder="0" height="0" scrolling="no" width="0"></iframe>
                  
               </div>
               <script type="text/javascript">var taxonomies = ["MED00300", "MED00460"];</script>
               </div>
            
            <div class="most-links-box ">
               
               <div class="most-header">
                  
                  <h3>Most</h3><ul class="most-headings"><li class="most-cur-sel"><a href="#">Most Read</a></li><li><a href="#">Most Cited</a></li></ul>
                  
               </div>
               
               <ul>
                  <li class="most-cur-sel">
                     <h4>Most Read</h4>
                     	  
                     <div class="most-list">
                        	    
                        <ol>
                           <li class="first-item"><a href="http://jac.oxfordjournals.org/cgi/content/short/65/suppl_3/iii25?rss=1&amp;amp;ssource=mfr">Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria</a></li>
                           <li><a href="http://jac.oxfordjournals.org/cgi/content/short/66/suppl_2/ii11?rss=1&amp;amp;ssource=mfr">Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective)</a></li>
                           <li><a href="http://jac.oxfordjournals.org/cgi/content/short/47/5/565?rss=1&amp;amp;ssource=mfr">Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact</a></li>
                           <li><a href="http://jac.oxfordjournals.org/cgi/content/short/48/suppl_1/5?rss=1&amp;amp;ssource=mfr">Determination of minimum inhibitory concentrations</a></li>
                           <li class="last-item"><a href="http://jac.oxfordjournals.org/cgi/content/short/49/1/25?rss=1&amp;amp;ssource=mfr">Factors impacting on the problem of antibiotic resistance</a></li>
                        </ol>
                        	    <a href="http://jac.oxfordjournals.org/reports/mfr1.dtl" class="view-all">» View all Most Read articles</a>
                        	  
                     </div>
                     	
                  </li>
                  <li>
                     <h4>Most Cited</h4>
                     	
                     <div class="most-list">
                        	  
                        <ol>
                           <li class="first-item"><a href="http://jac.oxfordjournals.org/cgi/content/short/40/1/135?rss=1&amp;amp;ssource=mfc">Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility</a></li>
                           <li><a href="http://jac.oxfordjournals.org/cgi/content/short/59/2/165?rss=1&amp;amp;ssource=mfc">CTX-M: changing the face of ESBLs in Europe</a></li>
                           <li><a href="http://jac.oxfordjournals.org/cgi/content/short/48/suppl_1/5?rss=1&amp;amp;ssource=mfc">Determination of minimum inhibitory concentrations</a></li>
                           <li><a href="http://jac.oxfordjournals.org/cgi/content/short/52/1/1?rss=1&amp;amp;ssource=mfc">Synergy, antagonism, and what the chequerboard puts between them</a></li>
                           <li class="last-item"><a href="http://jac.oxfordjournals.org/cgi/content/short/61/2/273?rss=1&amp;amp;ssource=mfc">Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15</a></li>
                        </ol>
                        	  <a href="http://jac.oxfordjournals.org/reports/mfc1.dtl" class="view-all">» View all Most Cited articles</a>
                        	
                     </div>
                     
                  </li>
               </ul>
               
            </div>
            
            
            
         </div>
         
         
         
         <div id="oas_bottom" class="ad_hidden">
            <iframe id="id_advertframe_bottom" src="417_4.html" class="resize_ad usmonndchupfwwcnugwg" frameborder="0" height="0" scrolling="no" width="0"></iframe>
            
         </div>
         
         
         
         
         
         
         <div id="secondary_footer">
            
            <div id="issn">Online ISSN 1460-2091 - Print ISSN 0305-7453</div>
            
            
            <div id="copyright"><a href="http://www.oxfordjournals.org/our_journals/terms.html">Copyright ©</a>&nbsp;
               <span>2013</span>&nbsp;
               <a xmlns="http://schema.highwire.org/Site/Branding/Venice" href="http://www.bsac.org.uk/">British Society for Antimicrobial Chemotherapy</a> 
            </div>
            
         </div>
         
         <div id="primary_footer">
            
            <div id="site_logo">
               <strong><span>Oxford Journals</span></strong>
               <em><span>Oxford University Press</span></em>
               
            </div>
            
            
            <div id="third_nav">
               
               <ul>
                  <li><a href="http://www.oxfordjournals.org/site_map.html">Site Map</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/privacy_policy.html">Privacy Policy</a></li>
                  <li><a href="http://global.oup.com/cookiepolicy/?siteid=journals">Cookie Policy</a></li>
                  <li><a href="http://www.oxfordjournals.org/legal/legal_notices.html">Legal Notices</a></li>
                  <li><a href="http://www.oxfordjournals.org/faq/">Frequently Asked Questions</a></li>
               </ul>
               
            </div>
            
            
            <div id="other_oup_sites">
               
               <form action="http://www.oxfordjournals.org/service/redirect">
                  <div>
                     <label for="site_list">Other Oxford University Press sites:</label>
                     <select name="url" id="site_list">
                        <option value="http://www.oup.com">Oxford University Press</option>
                        <option value="http://www.oxfordjournals.org/china/">Oxford Journals China</option>
                        <option value="http://www.oxfordjournals.org/japan/">Oxford Journals Japan</option>
                        <option value="http://www.oup.com/uk/academic">Academic &amp; Professional books</option>
                        <option value="http://www.oup.com/oxed">Children's &amp; Schools Books</option>
                        <option value="http://www.oup.com/uk/dictionaries">Dictionaries &amp; Reference</option>
                        <option value="http://www.oup.co.uk/newdnb/">Dictionary of National Biography</option>
                        <option value="http://www.oup.com/uk/digital_reference">Digital Reference</option>
                        <option value="http://www.oup.com/elt/">English Language Teaching</option>
                        <option value="http://www.oup.com/uk/textbooks">Higher Education Textbooks</option>
                        <option value="http://www.oup.co.uk/ieu/">International Education Unit</option>
                        <option value="http://www.oup.com/uk/law">Law</option>
                        <option value="http://www.oup.com/uk/medicine">Medicine</option>
                        <option value="http://www.oup.com/uk/music">Music</option>
                        <option value="http://www.oup.com/online">Online Products &amp; Publishing</option>
                        <option value="http://oxfordbibliographiesonline.com">Oxford Bibliographies Online</option>
                        <option value="http://oxforddictionaries.com">Oxford Dictionaries Online</option>
                        <option value="http://www.oed.com">Oxford English Dictionary</option>
                        <option value="http://www.oxfordlanguagedictionaries.com">Oxford Language Dictionaries Online</option>
                        <option value="http://www.oxfordscholarship.com">Oxford Scholarship Online</option>
                        <option value="http://www.oup.com/uk/reference">Reference</option>
                        <option value="http://www.oup.com/uk/rights">Rights and Permissions</option>
                        <option value="http://www.oup.com/uk/booksellers">Resources for Retailers &amp; Wholesalers</option>
                        <option value="http://www.oup.com/uk/corporate">Resources for the Healthcare Industry</option>
                        <option value="http://www.oup.com/vsi">Very Short Introductions</option>
                        <option value="http://www.oup.com/worldsclassics">World's Classics</option></select>
                     
                     <input src="go_001.gif" alt="Go" class="inline_button" type="image">
                     
                  </div>
               </form>
               
            </div>
            
         </div>
         <script type="text/javascript" src="oup.cookiepolicy.pack.js" defer="defer"></script>
         <script type="text/javascript" src="hw-publisher-baynote.js" defer="defer"></script>
         <script defer="defer" src="jquery-ui.min.js" type="text/javascript"></script>
         <script defer="defer" src="jcarousellite.js" type="text/javascript"></script>
         <script defer="defer" src="pf_oiunderbarinit.js" type="text/javascript"></script>
         <script defer="defer" src="underbar_local.js" type="text/javascript"></script>
         <script defer="defer" type="text/javascript">

    function fnc_onDomLoaded() {
        var query_context = getQueryContext();
        PF_initOIUnderbar(query_context,":QS:default","","JRN"); 
        PF_insertOIUnderbar(0);
    };
    if (window.addEventListener) { 
        window.addEventListener('load', fnc_onDomLoaded, false); 
    } else if (window.attachEvent) { 
        window.attachEvent('onload', fnc_onDomLoaded); 
    } 
</script>
         <script type="text/javascript">

        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script src="ga.js" type="text/javascript"></script><script type="text/javascript">

        try {
        var pageTracker = _gat._getTracker("UA-189672-16");
        pageTracker._setDomainName(".oxfordjournals.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   
<div id="fancybox-tmp"></div><div id="fancybox-loading"><div></div></div><div id="fancybox-overlay"></div><div id="fancybox-wrap"><div id="fancybox-outer"><div class="fancybox-bg" id="fancybox-bg-n"></div><div class="fancybox-bg" id="fancybox-bg-ne"></div><div class="fancybox-bg" id="fancybox-bg-e"></div><div class="fancybox-bg" id="fancybox-bg-se"></div><div class="fancybox-bg" id="fancybox-bg-s"></div><div class="fancybox-bg" id="fancybox-bg-sw"></div><div class="fancybox-bg" id="fancybox-bg-w"></div><div class="fancybox-bg" id="fancybox-bg-nw"></div><div id="fancybox-content"></div><a id="fancybox-close"></a><div id="fancybox-title"></div><a href="javascript:;" id="fancybox-left"><span class="fancy-ico" id="fancybox-left-ico"></span></a><a href="javascript:;" id="fancybox-right"><span class="fancy-ico" id="fancybox-right-ico"></span></a></div></div><div aria-labelledby="ui-dialog-title-underbar-wrapper" role="dialog" tabindex="-1" class="ui-dialog ui-widget ui-widget-content ui-corner-all " style="display: block; position: absolute; overflow: hidden; z-index: 1001; outline: 0px none; height: auto; width: 100%; left: 0px;"><div style="-moz-user-select: none; display: none;" unselectable="on" class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span style="-moz-user-select: none;" unselectable="on" id="ui-dialog-title-underbar-wrapper" class="ui-dialog-title">&nbsp;</span><a style="-moz-user-select: none;" unselectable="on" role="button" class="ui-dialog-titlebar-close ui-corner-all" href="#"><span style="-moz-user-select: none;" unselectable="on" class="ui-icon ui-icon-closethick">close</span></a></div><div class="ui-dialog-content ui-widget-content" style="display: block; height: auto; min-height: 121px; width: auto;" id="underbar-wrapper"><input id="hiddenColumns" type="hidden"><input id="hidArrCols" type="hidden"><input id="hidTotalColumns" type="hidden"><a style="display: none;" href="http://jac.oxfordjournals.org/content/45/4/undefined" target="_top" id="underbar-related" onclick="checkOpenURL(event);">See all related content</a><div style="display: none;" id="underbar-error">You must provide text in order to perform the search&nbsp;&nbsp;&nbsp;</div><div class="underbar-header" id="underbar-header"><div id="underbar-logo-cover"><img src="oi-logo.gif" alt="oi-logo" class="underbar-logoIndex" height="25" width="92"><label for="about the index" class="underbar-aboutLbl">About the Index</label><input style="display: none;" id="underbar-reveal-hide" name="underbar-reveal-hide" value="hide me" onclick="closeOIUnderbar();" type="button"><input id="underbar-reveal-show" name="underbar-reveal-show" value="show me" onclick="openOIUnderbar_About();" type="button"></div><div id="underbar-controls-cover"><div id="underbar-controls"><div id="underbar-counter"><img src="dot-inactive.png" id="underbar-dot-0" height="10" width="10"><img src="dot-inactive.png" id="underbar-dot-1" height="10" width="10"><img src="dot-inactive.png" id="underbar-dot-2" height="10" width="10"><img src="dot-inactive.png" id="underbar-dot-3" height="10" width="10"><img src="dot-inactive.png" id="underbar-dot-4" height="10" width="10"><img src="dot-inactive.png" id="underbar-dot-5" height="10" width="10"><img src="dot-inactive.png" id="underbar-dot-6" height="10" width="10"></div><div id="underbar-hide-div"><span style="display: none;" id="hide-link">Hide related links</span><span id="show-link">Show related links</span><input style="display: none;" id="underbar-hide" name="underbar-hide" value="hide me" onclick="closeOIUnderbar();" type="button"><input id="underbar-show" name="underbar-show" value="show me" onclick="openOIUnderbar(1);" type="button"><input style="display: none;" id="underbar-wait" name="underbar-wait" value="loading" type="button"></div></div><div class="underbar-search" id="underbar-search"><form action="http://jac.oxfordjournals.org/content/45/4/417.full" method="post" id="search-form" target="_blank"><label for="underbar-search-oxford-index">Search across all sources</label><input class="underbar-search-oxford-index underbar-search-text-color" id="underbar-search-oxford-index" value="in Oxford Index" onclick="removeDefaultText();" onkeydown="fncKeyDownSearch(event);" type="text">&nbsp;<input id="underbar-search-oxford-index-btn" class="underbar-submit underbar-logo" onclick="return submitSearch();" onkeydown="fncKeyDownSearch(event);" type="submit"></form></div></div></div><div style="display: none;" id="underbar-container"><div id="underbar-container-cover"></div></div><div style="display: none; width: 1901px;" id="underbar_aboutDiv"><div class="underbar-container-about" id="underbar-container-about0"><div style="width: 1852px;" class="underbar-about-columns" id="underbar-about-columns0"><div style="width: 588px;" class="underbar-about-column" id="underbar-about-column_00"><div class="underbar-about-content" id="underbar-about-content_00"><h3>About the Oxford Index</h3><ul><li><div class="alignAbout">A free search and discovery service, the Index helps users begin their research by providing a single, convenient search portal for trusted scholarship from Oxford and our partners.</div></li></ul></div></div><div style="width: 588px;" class="underbar-about-column" id="underbar-about-column_10"><div class="underbar-about-content" id="underbar-about-content_10"><h3>Related Content from Oxford University Press</h3><ul><li><div class="alignAbout">More than just a search tool, the Index provides smart recommendations for related content - from journal articles and scholarly monographs, to reference content, primary sources, and more - based on your research interests.</div></li></ul></div></div><div style="width: 588px;" class="underbar-about-column underbar-about-column-end" id="underbar-about-column_20"><div class="underbar-about-content" id="underbar-about-content_20"><h3>Search across All Books and Journals from Oxford</h3><ul><li><div class="alignAbout">The Oxford Index brings together, for the first time, the best of reference, journals, and scholarly works - one search delivers seamless discovery of all Oxford University Press online content.<br><br>Just enter your search term(s) in the box at the bottom right of your browser, and click the search icon to view your results in a new tab or window.</div></li></ul></div></div></div></div></div><div style="display: none;" id="underbar_noResultsDiv"><div class="underbar-container-noresult" id="underbar-container-about1"><div style="width: 1852px;" class="underbar-about-columns" id="underbar-about-columns1"><div style="width: 588px;" class="underbar-column-noresult" id="underbar-about-column_01"><div class="underbar-about-content" id="underbar-about-content_01"><h3></h3><ul><li><div class="alignAbout"></div></li></ul></div></div><div style="width: 588px;" class="underbar-column-noresult" id="underbar-about-column_11"><div class="underbar-about-content" id="underbar-about-content_11"><h3>NO RELATED LINKS DETECTED</h3><ul><li><div class="alignAbout">We can detect no related content links based on the main page you are currently viewing.<br><br>Related links from the Oxford Index will often be shown here when you are viewing search results or actual content pages on this site.<br><br>Check back here again when viewing other pages to see how the Oxford Index can help you navigate through online content from Oxford University Press and our publishing partners.</div></li></ul></div></div><div style="width: 588px;" class="underbar-column-noresult underbar-about-column-end" id="underbar-about-column_21"><div class="underbar-about-content" id="underbar-about-content_21"><h3>YOU CAN ALWAYS SEARCH THE INDEX DIRECTLY</h3><ul><li><div class="alignAbout">Use the search box on the right of the Oxford Index bar to search across all book and journal content available from Oxford University Press and our publishing partners.<br><br>Results will open in a new browser window or tab, so you can keep your place on this site while you explore related material.</div></li></ul></div></div></div></div></div></div></div><img style="display: none;" src="listener2"><img style="display: none;" src="listener2_001.dat"></body>
</html>
